News Focus
News Focus
Post# of 257443
Next 10
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: masterlongevity post# 87391

Sunday, 12/13/2009 10:23:59 AM

Sunday, December 13, 2009 10:23:59 AM

Post# of 257443
At 6 months the dimebon treated patients showed a 4 point (not 6) advantage on the ADAS-CoG vs. about 2-3 points seen from historical aricept trials. At 12 months advantage was even greater (6.9 points) .

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today